Insulet
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...
Latest News
4 days ago · zacks.com
Why Insulet (PODD) is a Top Growth Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 days ago · zacks.com
Insulet (PODD) Just Overtook the 20-Day Moving AverageAfter reaching an important support level, Insulet (PODD) could be a good stock pick from a technical perspective. PODD surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
5 days ago · seekingalpha.com
Insulet: Rivals Are Building Patch Pumps, But Insulet Already Owns The Pharmacy CounterInsulet is undervalued, trading at a sub-median multiple despite 20% revenue growth and expanding margins. PODD's pharmacy-based, fully disposable model and dominant new patient onboarding differentiate it from emerging tubeless competitors. Record gross margins (74.2%) and upgraded guidance—2026 revenue growth of 21%-22% and adjusted EPS growth above 30%—underscore strong operating leverage.
6 days ago · zacks.com
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
8 days ago · businesswire.com
For World Diabetes Day, Insulet Launches “Give Yourself the Freedom to” Campaign, Encouraging People with Diabetes to Prioritize Their Well-BeingACTON, Mass.--(BUSINESS WIRE)--In recognition of World Diabetes Day on November 14, 2026, Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its “Give Yourself the Freedom to” campaign designed to raise awareness of the often overlooked emotional and mental demands of living with diabetes and encourage people living with diabetes to prioritize their own well-being. “Living with d.
12 days ago · marketbeat.com
What Insulet (PODD) Said on Its Q3 Earnings CallInsulet NASDAQ: PODD reported third-quarter revenue of $842 million, up 19.2% on a reported basis and 19.6% on a constant-currency basis, as international growth outpaced the company's plans and U.S. performance landed within its guidance range.
13 days ago · seekingalpha.com
Insulet Corporation (PODD) Q3 2026 Earnings Call TranscriptInsulet Corporation (PODD) Q3 2026 Earnings Call Transcript
13 days ago · zacks.com
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesWhile the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
13 days ago · zacks.com
Insulet (PODD) Q3 Earnings and Revenues Surpass EstimatesInsulet (PODD) came out with quarterly earnings of $1.99 per share, beating the Zacks Consensus Estimate of $1.59 per share. This compares to earnings of $1.24 per share a year ago.
14 days ago · businesswire.com
Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in LondonACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 2026 Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 10:30 a.m. (GMT). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insulet Corpor.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove PODD